Company: FENC
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001558370-25-005563
Chunk: 1

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 1
---
 certain insiders, to approve certain amendments to Fennec’s 2020 Equity Incentive Plan; and |

| 6. | to transact such further or other business as may properly come before the Meeting or any adjournment thereof. |

Shareholders attending the Meeting online may register and log into the live audio webcast platform beginning at 9:45 a.m. EDT on the Meeting date. We would appreciate your early registration so that the Meeting may start promptly at 10:00 a.m. EDT on the Meeting date. The board of directors of Fennec has fixed 5:00 p.m. EDT on April 7, 2025 (t he“ Record Date”), as the record date for determining the holders of record of Common Shares who are entitled to receive notice of the Meeting and to attend and vote at the Meeting and any adjournment or postponement thereof. Fennec is holding a “hybrid” meeting that includes both an in-person and virtual online component. Only registered shareholders or proxyholders for registered shareholders will be permitted to attend the Meeting. In particular, Shareholders may attend the Meeting in person, online by visiting www.virtualshareholdermeeting.com/FENC2025, or may be represented at the Meeting by proxy. Proxies to be used at the Meeting must be received no later than 11:59 p.m. (EDT) on June 2, 2025 and, if the Meeting is postponed or adjourned, no later than 48 hours (excluding weekends and statutory holidays) preceding the reconvened Meeting. Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting to be held on June 3, 2025: This Notice, Management Proxy Circular and the Corporation’s Annual Report on Form 10-K are available to you on the Internet at www.proxyvote.com. We encourage you to access and review all of the important information contained in these materials before voting. DATED at Research Triangle Park, North Carolina this 25 thday of April, 2025. By Order of the Board of Directors of Fennec Pharmaceuticals
Inc. /s/ Khalid Islam Dr. Khalid Islam Chairman of the Board

Page1

#### ​​FENNEC PHARMACEUTICALS INC.MANAGEMENT PROXY CIRCULARUnless otherwise stated, information contained in this management proxy circular (the “Circular”) is given as of April 7, 2025.Except as otherwise indicated, all amounts are expressed in United